Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.
Tiziana Life Sciences announces $4 million grant awarded by NIH to study anti-CD3 in Alzheimer’s disease: New York Saturday, September 21, 2024, 14:00 Hrs [IST] Tiziana Life Sci ...